EPIRUBICIN HYDROCHLORIDE (EPIRUBICIN HYDROCHLORIDE) — FDA Approval NDA050807 (HOSPIRA)
EPIRUBICIN HYDROCHLORIDE (EPIRUBICIN HYDROCHLORIDE) — FDA Approval NDA050807 (HOSPIRA) is one of 9,000 drug approvals in the DrugApprovals dataset. Key details — Brand name: EPIRUBICIN HYDROCHLORIDE; Active ingredients: EPIRUBICIN HYDROCHLORIDE; Application number: NDA050807.
| Brand name | EPIRUBICIN HYDROCHLORIDE |
|---|---|
| Active ingredients | EPIRUBICIN HYDROCHLORIDE |
| Application number | NDA050807 |
| Sponsor | HOSPIRA |
| Dosage form | POWDER |
| Route | INTRAVENOUS |
| Marketing status | Discontinued |
| Products in application | 2 |
| First approval date | 20060915 |
| Source | openFDA Drugs@FDA |
$1499/mo
Try DrugApprovals →